Clinical Trials Logo
  1. Home
  2. Colon Adenocarcinoma
  3. NCT04526314
  4. Details
NCT04526314 Clinical Trial

Treatment and Outcomes of Stage III Colon Cancer in Patients 80 Years of Age and Older

Colon Adenocarcinoma Clinical Trial

Official title:
Treatment and Outcomes of Stage III Colon Cancer in Patients 80 Years of Age and Older

Clinical Trial Details — Status: Completed

Administrative data
NCT number NCT04526314
Other study ID # 908270
Secondary ID
Status Completed
Phase
First received
Last updated
Start date January 1, 2018
Est. completion date July 1, 2020

Study information
Verified date August 2020
Source Registre des Tumeurs Digestives du Finistère
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The objective of this study was to assess survival trends in elderly patients with stage III colon cancer

Description:

This retrospective population-based study included patients aged 80 years and older with stage III colon adenocarcinoma who underwent surgery between 2007 and 2014.

Recruitment information / eligibility
Status Completed
Enrollment 308
Est. completion date July 1, 2020
Est. primary completion date January 1, 2020
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 80 Years and older
Eligibility Inclusion Criteria:

• Stage 3 colon adenocarcinoma

Exclusion Criteria:

- Rectal tumors

- Patients receiving neo-adjuvant chemotherapy or radiotherapy

- Tumours of the appendix

- Tumours with histology other than adenocarcinoma

Study Design

Related Conditions & MeSH terms

Intervention

Other:
• observational
observational

Locations
Country Name City State
France Registre de tumeurs digestives du Finistère Brest

Sponsors (1)
Lead Sponsor Collaborator
Registre des Tumeurs Digestives du Finistère

Country where clinical trial is conducted

France, 

Outcome
Type Measure Description Time frame Safety issue
Primary Overall survival months 2007-2014
See also
  Status Clinical Trial Phase
Completed NCT04003181 - The Pathogenesis of Chronic Diarrhoea After Treatment for Cancer in Cecum and the Ascending Colon N/A
Active, not recruiting NCT04057274 - Acute Effect of modeRate-intensity aerOBIc Exercise on Colon Cancer Cell Growth N/A
Completed NCT02127359 - Whole-Exome Sequencing (WES) of Cancer Patients
Completed NCT00096278 - Fluorouracil, Leucovorin, and Oxaliplatin With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for Stage II or Stage III Colon Cancer Phase 3
Active, not recruiting NCT02912559 - Combination Chemotherapy With or Without Atezolizumab in Treating Patients With Stage III Colon Cancer and Deficient DNA Mismatch Repair Phase 3
Completed NCT02569723 - Oxaliplatin Microdosing Assay in Predicting Exposure and Sensitivity to Oxaliplatin-Based Chemotherapy N/A
Recruiting NCT05746195 - Optimization of Adaptive Text Messages for Cancer Survivors (OATS II) N/A
Active, not recruiting NCT03365882 - S1613, Trastuzumab and Pertuzumab or Cetuximab and Irinotecan Hydrochloride in Treating Patients With Locally Advanced or Metastatic HER2/Neu Amplified Colorectal Cancer That Cannot Be Removed by Surgery Phase 2
Completed NCT02393755 - Nintedanib and Capecitabine in Treating Patients With Refractory Metastatic Colorectal Cancer Phase 1/Phase 2
Recruiting NCT05710406 - Testing the Use of BRAF-Targeted Therapy After Surgery and Usual Chemotherapy for BRAF-Mutated Colon Cancer Phase 2/Phase 3
Recruiting NCT06017141 - Inhalational or Intravenous Anesthesia During Surgery for Patients With Colon Cancer, VIVA Study Phase 2
Active, not recruiting NCT03436563 - M7824 in Patients With Metastatic Colorectal Cancer or With Advanced Solid Tumors With Microsatellite Instability Phase 1/Phase 2
Recruiting NCT05482516 - Evaluating Novel Therapies in ctDNA Positive GI Cancers Phase 3
Completed NCT02368886 - Lower or Standard Dose Regorafenib in Treating Patients With Refractory Metastatic Colorectal Cancer Phase 2
Active, not recruiting NCT02863107 - Young-Onset Colorectal Cancer
Active, not recruiting NCT04963283 - Study of Cabozantinib and Nivolumab in Refractory Metastatic Microsatellite Stable (MSS) Colorectal Cancer Phase 2
Recruiting NCT06414304 - Dynamics of MSI and Genomic Profile of Colorectal Cancer In the Course of Immune Checkpoint Inhibitor Therapy
Completed NCT05872334 - The Safety and Feasibility of MONOFIX on Fascial Closure of Mid-line Wound After Minimally Invasive Colorectal Cancer Surgery N/A
Not yet recruiting NCT06426927 - PeLear CCC: Proyecto Latino Contra Cancer Colorectal N/A
Completed NCT03949777 - Validation of Aer-O-Scope Colonoscope System Cecal Intubation N/A